Tag

Patent Value

Oct 29 2020
0

LOT Network Report 2020

By | Publication | No Comments

What do IBM, Continental and Olympus all have in Common? They’ve all taken steps to maximize the value of their patents, they’ve reduced the risk of PAE litigation and they joined the LOT Network in 2020.

Richardson Oliver Law Group, Cipher, and LOT Network have just launched a report that discusses the 2.7 million assets under the LOT protection umbrella that companies like IBM and Continental have opted into.

LOT Network Report 2020: Why the largest patent portfolio in the world reduces PAE risk delves into the following key points:

  • Patent assertion entity risk,
  • LOT Network today,
  • The LOT Network portfolio,
  • and a look into what the future holds.

“LOT Network Report 2020.” Seddon et. al. LOT Portfolio Webinar and Report (October 2020), available here.

Apr 08 2018
0

“So, What’s the Value of Your Patent Strategy? Getting From Assumptions to Numbers.” Richardson et. al. IPWatchdog (April 2018)

By | Publication | No Comments

10,000+ patents, spending $10M’s per year, cross-licenses, and license potential with dozens of companies, what’s the value of the portfolio to the business? Is your patent strategy valuable to your company? How? OK, tag you are it, what is the answer? The problem seems intractable. In previous articles, we have discussed how to determine your general patent risk and how to put a number on it. But where do you start when you are trying to estimate the value of your patent strategy?

“So, What’s the Value of Your Patent Strategy? Getting From Assumptions to Numbers.” Richardson et. al. IPWatchdog (April 2018), available here.

Mar 13 2018
1

“Building a High Value Patent Portfolio: Where Strength Meets Quality.” Quinn et. al. IPWatchdog Webinar (March 2018)

By | Events | No Comments

Join Gene Quinn, patent attorney and founder of IPWatchdog.com and Erik Reeves, Founder of AcclaimIP and CTO of Anaqua, and Kent Richardson for a free webinar discussion on building a portfolio versus buying patents, identifying gaps in your patent coverage, and unlocking the secrets of your own patent portfolio to identify needs.

Watch the webinar here.

“Building a High Value Patent Portfolio: Where Strength Meets Quality.” Quinn et. al. IPWatchdog Webinar (March 2018), available here.

 

Aug 09 2017
0

“Patent Quality Isn’t the Question. Patent Value Is the Question.” Richardson et. al. IPWatchdog (August 2017)

By | Publication | No Comments

Why is patent value a better metric to use to set patent strategy? What sources of patent value can be identified for high technology companies? We review how patents are used and how they can be valued based upon their use.

“Patent Quality Isn’t the Question. Patent Value Is the Question.” Richardson et. al. IPWatchdog (August 2017), available here.

Aug 31 2016
0

“When Do Operating Companies Sell Their Patents?” Richardson et. al. IPWatchdog (August 2016)

By | Publication | No Comments

What causes operating companies to sell their patents? Our intuition tells us that patent sales take place when the seller is in financial distress or the company is underperforming. We wanted to test whether the data aligned with our intuition.

“When Do Operating Companies Sell Their Patents?” Richardson et. al. IPWatchdog (August 2016), available here.

Aug 30 2016
0

When do Operating Companies Sell their Patents?

By | News | No Comments

What causes operating companies to sell their patents? Our intuition tells us that patent sales take place when the seller is in financial distress or the company is underperforming. We asked ourselves whether data aligned with our intuition.

We looked at transaction data for sales from corporations. We studied the financial condition of 20 companies across 41 transactions over the last 6 years (post 2008 financial crisis) and looked for correlations between a company’s financial health and the sale of patents. We used sales from corporations to NPEs as a proxy for all corporate patent sales. In the analysis, we found that 78% of large patent sales (>= 10 patents transferred) occurred when the companies were underperforming the QQQ ETF (an exchange-traded fund based on the Nasdaq-100 Index, which was used as a proxy for the market). Further, including the smaller transactions (4-9 patents transferred), the overall share of transactions that occurred when the companies were underperforming the QQQ ETF was 71%.

Read the rest of the article at IPWatchdog.